Selected article for: "capsid protein and monoclonal antibody"

Author: Ahanchian, Hamid; Jones, Carmen M; Chen, Yueh-sheng; Sly, Peter D
Title: Respiratory viral infections in children with asthma: do they matter and can we prevent them?
  • Document date: 2012_9_13
  • ID: 0mnsm6s4_54
    Snippet: The monoclonal antibody to the cellular ICAM-1 was not effective. CFY196 (Coldsol) is a nasal spray multivalent Fab fusion proteins against ICAM-1 with a better avidity and in vitro potency against HRV [178] . Tremacamra, a soluble intercellular adhesion molecule 1 reduced the severity of experimental rhinovirus infection [179] . Pleconaril, an orally administered antiviral drug, acts by binding to a hydrophobic pocket in viral protein 1, and sta.....
    Document: The monoclonal antibody to the cellular ICAM-1 was not effective. CFY196 (Coldsol) is a nasal spray multivalent Fab fusion proteins against ICAM-1 with a better avidity and in vitro potency against HRV [178] . Tremacamra, a soluble intercellular adhesion molecule 1 reduced the severity of experimental rhinovirus infection [179] . Pleconaril, an orally administered antiviral drug, acts by binding to a hydrophobic pocket in viral protein 1, and stabilizes the protein capsid so that the virus cannot release its RNA genome into the target cell. Outcomes of clinical trials with pleconaril have revealed mixed results and new compounds are currently being developed [180] .

    Search related documents:
    Co phrase search for related documents
    • adhesion molecule and clinical trial: 1, 2, 3, 4, 5
    • adhesion molecule and experimental rhinovirus infection: 1
    • adhesion molecule and hydrophobic pocket: 1
    • adhesion molecule and intercellular adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adhesion molecule and monoclonal antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral drug and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and hydrophobic pocket: 1, 2, 3, 4, 5
    • antiviral drug and monoclonal antibody: 1, 2, 3, 4, 5, 6
    • antiviral drug and new compound: 1, 2, 3, 4, 5
    • capsid protein stabilize and protein stabilize: 1, 2
    • cellular monoclonal antibody and monoclonal antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • clinical trial and monoclonal antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical trial and new compound: 1
    • experimental rhinovirus infection and intercellular adhesion molecule: 1
    • Fab fusion and monoclonal antibody: 1, 2
    • Fab fusion protein and monoclonal antibody: 1, 2
    • hydrophobic pocket and intercellular adhesion molecule: 1
    • hydrophobic pocket and monoclonal antibody: 1, 2
    • intercellular adhesion molecule and monoclonal antibody: 1, 2, 3